Number of the records: 1
Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses
- 1.
SYSNO 0523540 Title Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses Author(s) Dölen, Y. (NL)
Valente, M. (NL)
Tagit, O. (NL)
Jäger, Eliezer (UMCH-V) [SUPRAMOL] ORCID, RID
van Dinther, E. A. W. (NL)
van Riessen, N. K. (NL)
Hrubý, Martin (UMCH-V) [SUPRAMOL] RID, ORCID
Gileadi, U. (GB)
Cerundolo, V. (GB)
Figdor, C. G. (NL)Corespondence/senior Figdor, C. G. - Korespondující autor Source Title Oncoimmunology. Roč. 9, č. 1 (2020), s. 1-14 Article number 1738813 Document Type Článek v odborném periodiku Grant GA17-07164S GA ČR - Czech Science Foundation (CSF), CZ - Czech Republic 686089, XE - EU countries Institutional support UMCH-V - RVO:61389013 Language eng Country GB Keywords cancer vaccines * nanoparticle biodistribution * iNKT cells URL https://www.tandfonline.com/doi/full/10.1080/2162402X.2020.1738813 Permanent Link http://hdl.handle.net/11104/0308171
Number of the records: 1